Table of Contents
What changed
Total income fell 12.0% to $15.2m and profit before tax fell by the same 12.0% to $13.6m. NPAT fell more sharply, down 18.2% to $12.2m, because the effective tax rate climbed to 9.9% from 3.1%. Operating cash flow swung to a $5.9m inflow from a $23.8m outflow in HY22, and closing cash rose to $3.6m from $2.4m. The balance sheet contracted materially: total assets fell 21.2% to $179.5m and total equity fell by an almost identical $47.8m to $178.1m, consistent with portfolio value compression rather than any leverage change (total liabilities remain trivial at $1.4m). The interim dividend was cut 19% to 1.36 cents per share.
What matters
- The earnings gap is tax-driven, not operating. PBT growth of -12.0% is the cleaner read; the wider -18.2% NPAT decline is fully explained by the effective tax rate tripling from 3.1% to 9.9%. No discontinued operations or special items are disclosed.
- The equity base shrank by $47.8m (-21.2%) while reported profit was $12.2m. The gap implies unrealised portfolio markdowns and/or distributions are materially larger than the period's realised return. For a vehicle of this shape, the equity movement is the substantive economic story, not the income-statement line.
- Dividend policy tightened. The interim per-share cut to 1.36c lifts the payout ratio on NPAT to 30.0% from 25.8% prior — so the dividend has been pared, but by less than earnings. Sustainability on a smaller capital base is the relevant question.
Expectations
No forward work, operating target, or guidance was supplied, and the FY22 anchor figure is a loss that reflects portfolio valuation movements rather than a like-for-like revenue base — so annualising HY23's $15.2m to $30.5m is arithmetically possible but not analytically meaningful. The release does support that period-over-period income generation remained positive and that cash funding improved sharply; it does not support any view on second-half shape or full-year outcome.
Quality of result
Mixed. The income line itself is modest in absolute terms and dominated by dividend income ($1.9m disclosed), which is inherently lumpy. The headline improvement worth flagging is operating cash flow, which moved $29.7m favourably year-on-year — but HY22's $23.8m outflow looks like an outlier (the FY22 full-year OCF was only -$18.0m, implying a $5.8m H2 inflow), so the HY23 print is closer to a normalisation than a structural step-up. Working capital moves are immaterial given receivables of just $0.1m. The -$47.8m equity contraction alongside $12.2m of reported NPAT is the clearest signal that the income statement is not capturing the full economic result for the period.
Unresolved
- What drove the effective tax rate from 3.1% to 9.9%, and is the higher rate the new base?
- How much of the $47.8m equity decline reflects unrealised portfolio losses versus dividends and buy-backs?
- What is the NTA per share at balance date, and how does the 1.36c interim sit against a full-year distribution policy?
- Gross borrowings and any concentration in the underlying portfolio are not disclosed in the supplied extraction.
This briefing cannot assess portfolio-level performance, NTA, or the market-price context needed to judge the result against the vehicle's investment mandate.
Key metrics
| Metric | HY23 | HY22 | Change |
|---|---|---|---|
| Revenue | $15.2m | $17.3m | -12.0% ↓ |
| Net profit after tax | $12.2m | $14.9m | -18.2% ↓ |
| Net cash inflow from operating activities | $5.9m | −$23.8m | +124.7% ↑ |
| Interim dividend per share | 1.4c | 1.7c | -19.0% ↓ |
| Operating profit | $13.6m | $15.4m | -12.0% ↓ |
| Profit before tax | $13.6m | $15.4m | -12.0% ↓ |
| Cash and cash equivalents | $3.6m | $2.4m | +50.9% ↑ |
| Total assets | $179.5m | $227.9m | -21.2% ↓ |
Reference: annolyse.ai/briefings/brm-hy23
Analytical metrics
| Metric | HY23 | HY22 | Context |
|---|---|---|---|
| PBT growth | -12.0% | — | cleaner earnings measure |
| Effective tax rate | 9.9% | 3.1% | — |
| Debtor days | 1.3 | 0.8 | +0.5 days |
| Operating working capital | $0.1m | $0.1m | +$0.0m absorbed |
| Trade debtors | $0.1m | $0.1m | +$0.0m |
| Payout ratio vs NPAT | 30.0% | — | — |
| ROE (annualised) | 12.1% | 15.1% | Weakening |
| Profit from continuing operations | $12.2m | $14.9m | −$2.7m |
Reference: annolyse.ai/briefings/brm-hy23
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.